PELTHOS THERAPEUTICS INCPTHS
ASignal's systematic analysis rates PTHS as Bearish.
Reflects the latest available analysis · analyzed Oct 25, 2026
The case on PTHS
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Gross margin of 75.58% indicates strong pricing power
- Current ratio of 1.98x suggests reasonable short-term liquidity
- RSI at 31.58 indicates near oversold condition, potential for reversal
- Negative MACD histogram and price below SMA20/SMA50 indicate downtrend
- Free cash flow of -$36.57M and negative operating cash flow signal financial burn
- Negative profit and operating margins (net margin: -199.50%, operating margin: -101.41%)
- Price to book ratio of -42.08x reflects negative book value due to accumulated losses
- No news coverage or Reddit mentions, indicating low market sentiment visibility
See the full verdict on PTHS
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes PTHS
Most investors never get a second opinion, let alone several. ASignal runs PTHS past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.